NCM
DERM icon

Nantahala Capital Management’s Journey Medical DERM Stock Holding History

Nantahala Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-348,663
Closed -$955K – 132
2023
Q3 		$955K Buy
348,663
+169,957
+95% +$380K 0.08% 105
2023
Q2 		$284K Sell
178,706
-33,651
-16% -$54.1K 0.03% 108
2023
Q1 		$333K Sell
212,357
-13,639
-6% -$25.4K 0.03% 110
2022
Q4 		$434K Buy
+225,996
New +$447K 0.03% 100

Other funds holding DERM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $421M AUM 30.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Nantahala Capital Management's DERM Position: Q4 2023 in Review

Nantahala Capital Management sold out of Journey Medical (DERM) in Q4 2023, closing a stake of 348,663 shares — an estimated $955K sold.

Nantahala Capital Management first reported a position in DERM in Q4 2022 and held it in 4 quarters. The position peaked at $955K in Q3 2023. 36 funds tracked by Wall St. Rank hold DERM as of Q4 2023.

  • Nantahala Capital Management reported no remaining Journey Medical position as of Q4 2023 after selling out during the quarter.
  • Nantahala Capital Management sold 348,663 Journey Medical shares in Q4 2023, an estimated $955K.
  • Nantahala Capital Management first reported a position in Journey Medical in Q4 2022 and held it in 4 quarters.
  • Nantahala Capital Management's Journey Medical position peaked at $955K in Q3 2023.
  • 36 funds tracked by Wall St. Rank held Journey Medical as of Q4 2023.

Based on Nantahala Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.